CellPoint has successfully closed a new funding round, securing $34.0M in fresh capital. This substantial investment provides a significant financial injection for the company, signaling a robust vote of confidence from its backers as it looks to its next phase of development.
The capital infusion comes from a notable roster of investors, including Toscafund and Penta Capital LLP, whose participation underscores the perceived potential within CellPoint's operations.


















